Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Monday, February 16, 2026

Can Chat GPT Find Medicaid Genetic Test Prices? (81420 trisomy, 81519 oncotype)

›
 It's easy to look up Medicare prices for genomic tests - there is one national Clinical Laboratory Fee Schedule CLFS. It's hard to...

HHS Releases Massive Medicaid Database: Fighting Fraud, Other Uses

›
CMS has long released provider-level, CPT-coded utilization or payment data.  (See exactly which CPT codes your doctor was paid for in 2023....

Breaking the Biomarker Bottlenecks: Why CDx and Digital Pathology Just Got Much More Strategic

›
Breaking the Biomarker Bottlenecks: Why CDx and Digital Pathology Just Got Much More Strategic Below, Chat GPT 5.2 summarizes a pair of arti...
Saturday, February 14, 2026

Get It Here: Another Detailed RFK Jr Interview with Podcast Host

›
On February 1, I published a detailed review of a long interview between RFK Jr and podcast host Katie Miller ( here ).  Regular news covere...
Friday, February 13, 2026

CMS Updates PAMA Reporting Page - Timelines are Short

›
 PAMA lab price reporting, for CMS median rate-setting, has been frozen since 2019.   Based on section 6226 of the February 3 federal budget...
Thursday, February 12, 2026

Podcast Scan: Owkin's Podcast with Jorge Reis-Filho

›
Owkin is a French company on the cutting edge of genomic/cellular/biomarker/AI discovery. They have 63 videos on YouTube , many of them vide...

CMS Gapfill: Spring 2026 Update & What Will Happen

›
Each fall, CMS determines which of 100-odd new lab codes are crosswalked and which are "gapfilled," meaning priced by MACs - for...

Amal Thommil Updates Decibio MRD Coverage (February 2026)

›
 Amal Thommil at DeciBio updates us on coverage for minimal residual disease testing (MRD). See his chart here . click to enlarge

AI VERSION: My Heart Skipped a Beat, CMS Proposes X1-X2 Modifiers for NCD 90.2 (NGS in Cancer)

›
This blog issued as AI version (below) and my original human written version . ### Header:  CMS proposes X1/X2 modifiers to encode cancer s...

HUMAN VERSION: My Heart Skipped a Beat: CMS Proposed X1, X2 Modifiers for NCD 90.2 NGS in Cancer

›
This blog issued as my human-written version here, and an AI-written version adjacent . ## CMS has an NCD, 90.2, which was designed in 2017 ...

This May Save Your (Reimbursement Nerd) Life Someday: CMS Defines CR Implementation Date vs Effective Date!

›
Header:  CMS issues MAC instructions (e.g. for NCDs) by "Change Release" instructions, which are also public.  Every new requirem...
Tuesday, February 10, 2026

Excellent MedTech Podcast: From R&D to FDA to Commercialization (Dr Doug Kelly, FDA)

›
Heard an excellent podcast today on MedtechTalk, featuring Douglas Kelly MD MBA , a physician and venture capitalist who served 2020-2025 as...

Big News for Digital Pathology: AMA Appears Set to Use CATEGORY III for Whole Slide Imaging / AI

›
It's no secret that AMA CPT PLA made a half-dozen codes for whole-slide imaging 3 to 4 years ago, and then seemingly imposed a "mor...
Monday, February 9, 2026

Medical History: Specialties Draw Opposite Conclusions from the Same Data

›
 I just came back  from the AMA CPT meeting, where dozens of topics are debated "pro and con" with opposing stakeholders. I was re...

AMA CPT: Important Clarifications to Confidentiality Policy

›
At the February 5-6, 2026 AMA CPT meeting, the first couple hours are devoted to "new news" rather than code review. There was an ...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.